SAHA and/or MG132 reverse the aggressive phenotypes of glioma cells: An in vitro and vivo study.

about

The p53 Pathway in Glioblastoma ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid

P2860

Q57162865-6002F110-C1CC-4955-9710-9B202B17719B Q58792092-3995C089-333B-4C95-B4D2-C65AAC6F5E8B

P2860

SAHA and/or MG132 reverse the aggressive phenotypes of glioma cells: An in vitro and vivo study.

Item

http://www.wikidata.org/entity/Q37709442

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

SAHA and/or MG132 reverse the ...... s: An in vitro and vivo study.

@en

SAHA and/or MG132 reverse the ...... s: An in vitro and vivo study.

@nl

type

Item

label

SAHA and/or MG132 reverse the ...... s: An in vitro and vivo study.

@en

SAHA and/or MG132 reverse the ...... s: An in vitro and vivo study.

@nl

prefLabel

SAHA and/or MG132 reverse the ...... s: An in vitro and vivo study.

@en

SAHA and/or MG132 reverse the ...... s: An in vitro and vivo study.

@nl

P1476

SAHA and/or MG132 reverse the ...... s: An in vitro and vivo study.

@en

P2093

Hua-Chuan Zheng

http://www.w3.org/2001/XMLSchema#string

Jia-Jie Liu

http://www.w3.org/2001/XMLSchema#string

Ke-Qiang Huang

http://www.w3.org/2001/XMLSchema#string

Shuai Shi

http://www.w3.org/2001/XMLSchema#string

Shuang Zhao

http://www.w3.org/2001/XMLSchema#string

Xiang-Hong Yang

http://www.w3.org/2001/XMLSchema#string

Xue-Feng Yang

http://www.w3.org/2001/XMLSchema#string

Yang Gao

http://www.w3.org/2001/XMLSchema#string

Zhi-Juan Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Cdc2: a monopotent or pluripotent CDK?

Altered histone modifications in gliomas

Biodegradable thermosensitive hydrogel for SAHA and DDP delivery: therapeutic effects on oral squamous cell carcinoma xenografts

Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo

Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies.

SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells.

Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells.

UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

P304

3156-3169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.13680

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27911270

http://www.w3.org/2001/XMLSchema#string

P932

5356872

http://www.w3.org/2001/XMLSchema#string

SAHA and/or MG132 reverse the aggressive phenotypes of glioma cells: An in vitro and vivo study.

about

P2860

P2860

SAHA and/or MG132 reverse the aggressive phenotypes of glioma cells: An in vitro and vivo study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932